Sangamo Therapeutics
SGMO
#10416
Rank
S$39.57 M
Marketcap
S$0.09552
Share price
0.00%
Change (1 day)
-84.75%
Change (1 year)

Sangamo Therapeutics (SGMO) - Cash on Hand

Cash on Hand as of March 2026 : S$35.6 Million

According to Sangamo Therapeutics 's latest financial reports the company has S$35.6 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Sangamo Therapeutics - Cash on Hand chart (from 2000 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31S$26.89 M-52.8%
2024-12-31S$56.97 M-46.74%
2023-12-31S$0.10 B-71.26%
2022-12-31S$0.37 B-26.89%
2021-12-31S$0.50 B-40.01%
2020-12-31S$0.84 B73.64%
2019-12-31S$0.48 B-10.6%
2018-12-31S$0.54 B67.98%
2017-12-31S$0.32 B57.75%
2016-12-31S$0.20 B-30.22%
2015-12-31S$0.29 B25.02%
2014-12-31S$0.23 B101.09%
2013-12-31S$0.11 B51.32%
2012-12-31S$77.71 M-28.68%
2011-12-31S$0.10 B40.31%
2010-12-31S$77.65 M-34.88%
2009-12-31S$0.11 B28.62%
2008-12-31S$92.71 M-20.54%
2007-12-31S$0.11 B41.13%
2006-12-31S$82.68 M5.75%
2005-12-31S$78.18 M44.09%
2004-12-31S$54.26 M-27.18%
2003-12-31S$74.5 M-17.65%
2002-12-31S$90.47 M-20.65%
2001-12-31S$0.11 B3.59%
2000-12-31S$0.11 B769.86%
1999-12-31S$12.65 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
S$28.46 B 79,835.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$15.53 B 43,538.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$5.52 B 15,424.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
S$4.97 B 13,859.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$9.86 B 27,606.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$7.36 B 20,569.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$3.88 B 10,808.50%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$2.86 B 7,956.41%๐Ÿ‡บ๐Ÿ‡ธ USA